For instance, UPF3B is upregulated in esophageal carcinoma, stomach adenocarcinoma, hepatocellular carcinoma, and breast invasive carcinoma, whereas UPF3B was downregulated in kidney chromophobe, prostate adenocarcinoma, and thyroid carcinoma. Here, UPF3B is linked to hepatocellular carcinoma.